Porównaj metody
Przeglądaj wybrane metody obok siebie; wiersze, które się różnią, są wyróżnione.
| Skala Uzależnienia od Alkoholu (ADS)× | Addiction Severity Index (ASI)× | |
|---|---|---|
| Dziedzina | Psychiatria | Psychiatria |
| Rodzina | Process / pipeline | Process / pipeline |
| Rok powstania≠ | 1982 | 1980 |
| Twórca≠ | Harvey A. Skinner | A. Thomas McLellan |
| Typ≠ | Self-report questionnaire | Clinician-administered structured interview |
| Źródło pierwotne≠ | Skinner, H. A., & Allen, B. A. (1982). Alcohol dependence syndrome: measurement and validation. Journal of Abnormal Psychology, 91(3), 199–209. DOI ↗ | McLellan, A. T., Luborsky, L., Woody, G. E., & O'Brien, C. P. (1980). An improved diagnostic evaluation instrument for substance abuse patients: The Addiction Severity Index. Journal of Nervous and Mental Disease, 168(1), 26–33. DOI ↗ |
| Inne nazwy≠ | ADS | ASI, ASI-6 |
| Pokrewne | 3 | 3 |
| Podsumowanie≠ | The ADS is a 25-item self-report scale designed to measure the severity of alcohol dependence symptoms according to the alcohol dependence syndrome concept. Developed by Skinner and Allen in 1982, it focuses on dependence-specific features (withdrawal, tolerance, loss of control, continued use despite harm) rather than social consequences alone. The ADS is widely used in addiction medicine, treatment outcome research, and clinical settings to assess dependence severity, guide detoxification planning, and track treatment response in individuals with alcohol use disorder. | The ASI is a multidimensional, clinician-administered semi-structured interview assessing severity of substance use disorder and related psychosocial problems across seven domains: medical, employment, drug use, alcohol use, legal, family/social, and psychiatric. Developed by McLellan and colleagues in 1980 and refined through editions, it has become the gold standard comprehensive assessment tool in addiction medicine, substance abuse treatment programs, and research. The ASI provides both interview-derived severity ratings (0–9 per domain) and composite scores enabling treatment planning and outcome monitoring. |
| ScholarGateZbiór danych ↗ |
|
|